Ionic liquids as refolding additives: N′-alkyl and N′-(ω-hydroxyalkyl) N-methylimidazolium chlorides

Protein Science

Volumn 14, Issue 10, 2005, Pages 2693-2701

  Lange, Christian ^a   Patil, Ganesh ^a   Rudolph, Rainer ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Aggregation; Calorimetry; Ionic liquids; Refolding; Stability

Indexed keywords

CHLORIDE; EGG WHITE; IMIDAZOLE DERIVATIVE; SODIUM CHLORIDE;

ARTICLE; HYDROPHOBICITY; HYDROXYLATION; LIQUID; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN STABILITY; RENATURATION; SCREENING;

ANIMALS; ANTIBODIES, MONOCLONAL; CATIONS; CHLORIDES; IMIDAZOLES; MODELS, CHEMICAL; MURAMIDASE; OSMOLAR CONCENTRATION; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 25844440020     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.051596605     Document Type: Article

References (28)

1. Alfthan, K. , Sizmann, D., Soderlund, H., and Teeri, T.T. 1995. Properties of a single-chain antibody containing different linker peptides. Protein Eng. 8: 725-731.
2. Arakawa, T. and Tsumoto, K. 2003. The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Comm. 304: 148-152.
3. Baker, S.N., McCleskey, T.M., Pandey, S., and Baker, G.A. 2004. Fluorescence study of protein thermostability in ionic liquids. Chem. Commun. 2004: 940-941.
4. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
5. Brinkmann, U., Mattes, R.E., and Buckel, P. 1989. High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dna Y gene product. Gene 85: 109-114.
6. Brinkmann, U., Buchner, J., and Pastan, I. 1992. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: Influence of interdomain connections. Proc. Natl. Acad. Sci. 89: 3075-3079
7. ab-fragments produced in Escherichia coli. Biotechnology 9: 157-162.
8. De Bernardez-Clark, E., Schwarz, E., and Rudolph, R. 1999. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol. 309: 217-237.
9. de Diego, T., Lozano, P., Gmouh, S., Vaultier, M., and Iborra, J.L. 2004. Fluorescence and CD spectroscopic analysis of the α-chymotrypsin stabilization by the ionic liquid 1-ethyl-3-methylimidazolium bis[(trifluormethyl) sulfonyl]amide. Biotechnol. Bioeng. 88: 916-924.
10. Fahnert, B., Lilie, H., and Neubauer, P. 2004. Inclusion bodies: Formation and utilisation. Adv. Biochem. Eng. Biotechnol. 89: 93-142.
11. Fiedler, U. and Conrad, U. 1995. High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology 13: 1090-1093.
12. Gill, S.C. and von Hippel, P.H. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319-326.
13. Goldberg, M.E., Rudolph, R., and Jaenicke, R. 1991. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry 30: 2790-2797.
14. Hofmeister, F. 1888. Zur lehre von der wirkung der salze. II. Arch. Exp. Pathol. Pharmakol. 24: 247-260.
15. Kiefhaber, T., Rudolph, R., Kohler, H.-H., and Buchner, J. 1991. Protein aggregation in vivo: A quantitative model of the kinetic competition between folding and aggregation. Biotechnology 9: 825-829.
16. Kita, Y., Arakawa, T., Lin, T.Y., and Timasheff, S.N. 1994. Contribution of the surface free energy perturbation to protein-solvent interactions. Biochemistry 33: 15178-15189.
17. Kudou, M., Shiraki, K., Fujiwara, S., Imanaka, T., and Takagi, M. 2003. Prevention of thermal inactivation and aggregation of lysozyme by polyamines. Eur. J. Biochem. 270: 4547-4554.
18. Kragl, U., Eckstein, M., and Kaftzik, N. 2002. Enzyme catalysis in ionic liquids. Curr. Opin. Biotechnol. 13: 565-571.
19. Krause, M., Rudolph, R., and Schwarz, E. 2002. The non-ionic detergent Brij 58P mimics chaperone effects. FEBS Lett. 532: 253-255.
20. Lange, C. and Rudolph, R. 2005. Production of recombinant proteins for therapy, diagnostics and industrial research by in vitro folding. In Protein folding handbook (eds. T. Kiefhaber and J. Buchner), pp. 1245-1280. Wiley, Weinheim, Germany.
21. Lin, T.-Y. and Timasheff, S.N. 1996. On the role of surface tension in the stabilization of globular proteins. Protein Sci. 5: 372-381.
22. Lozano, P., de Diego, T., Guegan, J.-P., Vaultier, M., and Iborra, J.L. 2001. Stabilization of α-chymotrypsin by ionic liquids in transesterification reactions. Biotechnol. Bioeng. 75: 563-569.
23. Michaelis, U., Rudolph, R., Jarsch, M., Kopetzki, E., Burtscher, H., and Schumacher, G. 1995. Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase. U.S. patent 5,434,067.
24. Orsini, G., and Goldberg, M.E. 1978. The renaturation of reduced chymotrypsinogen A in guanidine HCl. J. Biol. Chem. 253: 3453-3458.
25. Park, S., and Kazlauskas, R.J. 2003. Biocatalysis in ionic liquids - Advantages beyond green technology. Curr. Opin. Biotechnol. 14: 432-437.
26. Reddy K., R.C., Lilie, H., Rudolph, R., and Lange, C. 2005. L-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci. 14: 929-935.
27. Rudolph, R. and Fischer, S. 1990. Process for obtaining renatured proteins. U.S. patent 4,933,434.
28. Rudolph, R., Fischer, S., and Mattes, R. 1995. Process for the activation of t-PA or Ing after genetic expression in prokaryotes. U.S. patent 5,453,363.